Thatsaphan Srithongkul1, Patompong Ungprasert2. 1. Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. 2. Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand. Electronic address: p.ungprasert@gmail.com.
Abstract
BACKGROUND: Recent studies have suggested a renal protective effect of coffee consumption against development of chronic kidney disease (CKD) although the results remain inconclusive. This systematic review and meta-analysis aimed to comprehensively investigate this association by summarizing all available data. METHODS: A systematic review was performed using MEDLINE and EMBASE database from inception to November 2019 to identify all cohort studies that compared the risk of developing CKD after index date among coffee-drinkers versus non-drinkers. Pooled risk ratio and 95% confidence interval (CI) were calculated using random-effect, generic inverse-variance method of DerSimonian and Laird. RESULTS: A total of 4 cohort studies comprising of 25,849 participants met the inclusion criteria and were analyzed in the meta-analysis. The meta-analysis found a significantly decreased risk of incident CKD among coffee-drinkers compared with non-drinkers with the pooled risk ratio of 0.87 (95% CI, 0.81-0.95; I2 of 57%). The funnel plot of this study was relatively symmetric and was not indicative of publication bias CONCLUSIONS: A significant association between coffee consumption and a lower risk of incident CKD was demonstrated in this study.
BACKGROUND: Recent studies have suggested a renal protective effect of coffee consumption against development of chronic kidney disease (CKD) although the results remain inconclusive. This systematic review and meta-analysis aimed to comprehensively investigate this association by summarizing all available data. METHODS: A systematic review was performed using MEDLINE and EMBASE database from inception to November 2019 to identify all cohort studies that compared the risk of developing CKD after index date among coffee-drinkers versus non-drinkers. Pooled risk ratio and 95% confidence interval (CI) were calculated using random-effect, generic inverse-variance method of DerSimonian and Laird. RESULTS: A total of 4 cohort studies comprising of 25,849 participants met the inclusion criteria and were analyzed in the meta-analysis. The meta-analysis found a significantly decreased risk of incident CKD among coffee-drinkers compared with non-drinkers with the pooled risk ratio of 0.87 (95% CI, 0.81-0.95; I2 of 57%). The funnel plot of this study was relatively symmetric and was not indicative of publication bias CONCLUSIONS: A significant association between coffee consumption and a lower risk of incident CKD was demonstrated in this study.
Authors: Yuko Yamaguchi; Marta Zampino; Ruin Moaddel; Teresa K Chen; Qu Tian; Luigi Ferrucci; Richard D Semba Journal: Metabolomics Date: 2021-01-11 Impact factor: 4.747
Authors: Sandra Wagner; Thomas Merkling; Nicolas Girerd; Erwan Bozec; Laurie Van den Berghe; Axelle Hoge; Michèle Guillaume; Mehmet Kanbay; Céline Cakir-Kiefer; Simon N Thornton; Jean-Marc Boivin; Ludovic Mercklé; Martine Laville; Patrick Rossignol; Julie-Anne Nazare Journal: Front Nutr Date: 2022-01-07
Authors: Seda Kaya; Mahmut Bodur; Merve İlhan Esgin; Funda Pınar Çakıroğlu; Ayşe Özfer Özçelik Journal: Int J Ment Health Addict Date: 2021-11-01 Impact factor: 3.836